Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 43 for “"WHO grade"”.

  1. Seizures in WHO grade 2 glioma: semiology and significance

    Background: WHO Grade 2 gliomas are a group of highly epileptogenic brain tumours. Seizures occur in the majority of patients and often at an early stage. How exactly these seizures are generated, their characteristics and their optimal management are not well understood. In addition, we also …

    whiterose Download PDF for Seizures in WHO grade 2 glioma: semiology and significance (opens in a new tab)

  2. Investigation of molecular subtypes of WHO grade II-IV gliomas by use of T2 mapping sequences in Magnetic Resonance Imaging

    … The revised World Health Organization (WHO) classification for tumors of the central nervous system, presented in 2016, included the molecular subtype of gliomas for the first time as this has a major influence on patient prognosis and response to therapy. It has been observed in several …

    fu-berlin Repository record for Investigation of molecular subtypes of WHO grade II-IV gliomas by use of T2 mapping sequences in Magnetic Resonance Imaging (opens in a new tab)

  3. Stellenwert der Verlaufsbeobachtung, operativen Tumorresektion und Monochemotherapie bei Oligodendrogliomen WHO Grad II

    INTRODUCTION Gliomas of histological WHO grades 2 and 3 show a heterogenous prognosis that largely depends on molecular tumor characteristics. Presence of 1p/19q codeletions distinguishes oligodendroglioma from astrocytoma among IDHmut gliomas. Both entities are associated with favourable outcome …

    lmu-germany Repository record for Stellenwert der Verlaufsbeobachtung, operativen Tumorresektion und Monochemotherapie bei Oligodendrogliomen WHO Grad II (opens in a new tab)

  4. Stellenwert und Komplikationsraten stereotaktischer Probenentnahmen in der Gliomdiagnostik und -therapie

    … patients diagnosed with IDH-mutant astrocytomas WHO grade 2 or 3 (n=183), either diagnosed by biopsy or resection, were further investigated for progression-free and overall survival. The cohort was stratified according to the postoperative strategy: wait-and-scan (n=98), radiotherapy (n=37) or …

    lmu-germany Repository record for Stellenwert und Komplikationsraten stereotaktischer Probenentnahmen in der Gliomdiagnostik und -therapie (opens in a new tab)

  5. An immunohistochemical analysis of the immune microenvironment in meningioma and its association with tumour recurrence

    … reviewed and classified according to the 2016 WHO classification of central nervous system tumours. Demographic and tumour characteristics were summarised, and meningioma incidence estimated. Where sufficient archival tissue remained, tissue microarrays (TMAs) were constructed. Sections were …

    auckland-ms Repository record for An immunohistochemical analysis of the immune microenvironment in meningioma and its association with tumour recurrence (opens in a new tab)

  6. Επιδημιολογική και ανοσολογική μελέτη ασθενών με γλοιώματα του ΚΝΣ

    … of gliomas, and their association with the WHO grading system and Overall Survival. Material and Methods: We have conducted a case-control study of 49 patients with gliomas and 30 healthy controls referred to the University Hospital of Ioannina. Blood sample was undertaken preoperative. We …

    greece Repository record for Επιδημιολογική και ανοσολογική μελέτη ασθενών με γλοιώματα του ΚΝΣ (opens in a new tab)

  7. Risk factors for haemorrhage in patients with haematological malignancies

    … haemorrhage (World Health Organization (WHO) grade 2 or above bleeding) and up to 10% have severe or life-threatening haemorrhage (WHO grade 3 or 4 bleeding). Hence our current management of these patients to prevent haemorrhage is sub-optimal. The aim of this thesis was to identify …

    oxford Repository record for Risk factors for haemorrhage in patients with haematological malignancies (opens in a new tab)

  8. Single-Voxel- versus Multi-Voxel-Protonen-MR-Spektroskopie bei verschiedenen intrakraniellen Läsionen

    … bestehen. Untersucht wurden Hirntumoren der WHO-Grade 2 bis 4, Metastasen und fokal-entzündliche Läsionen. Zusammenfassend ist die Unterscheidung zwischen normalem und pathologisch verändertem Hirngewebe am besten mit der Singelvoxel-Methode und Bildung der CHO/CRE-Ratio möglich. Zur …

    wurz-thes Repository record for Single-Voxel- versus Multi-Voxel-Protonen-MR-Spektroskopie bei verschiedenen intrakraniellen Läsionen (opens in a new tab)

  9. Functional Modelling of Heterogeneity in Paediatric Ependymoma

    … is the third most common pediatric brain tumour whose underlying biology is poorly understood. The current therapeutic options are limited to gross total resection and radiotherapy, which carry limitations and toxic side effects. Ependymomas are classified based on where in the central nervous …

    toronto-retro Repository record for Functional Modelling of Heterogeneity in Paediatric Ependymoma (opens in a new tab)

  10. A systems approach to the different grades and progression of human astrocytoma

    … from the least aggressive pilocytic astrocytoma (WHO grade 1) to the most aggressive glioblastoma (WHO grade 4). Molecular biomarkers or signatures—i.e., patterns of gene or protein expression that can reliably distinguish between each grade and provide insight into the underlying molecular events …

    uiuc Repository record for A systems approach to the different grades and progression of human astrocytoma (opens in a new tab)

  11. DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA

    Glioblastoma (WHO grade IV), the most frequently occurring glioma in adults, with an incidence rate of 3.22 per 100,000, has dismal prognosis with the median survival of 12-15 months after diagnosis. . The current standard of care involves maximal safe resection followed by radiotherapy in …

    nus Repository record for DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA (opens in a new tab) Download file for DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA (opens in a new tab)

  12. Μελέτη των μηχανικών ιδιοτήτων των γλοιωμάτων εγκεφάλου σε χειρουργικά ιστοτεμάχια

    … gliomas of different World Health Organization (WHO) grades, as well as the influence of histopathological traits and mechanical preconditioning on tumor and white matter elasticity. Methods: The elastic modulus was measured ex vivo on fresh tissue specimens acquired during craniotomy from the …

    greece Repository record for Μελέτη των μηχανικών ιδιοτήτων των γλοιωμάτων εγκεφάλου σε χειρουργικά ιστοτεμάχια (opens in a new tab)

  13. USING STATISTICAL METHOD TO REVEAL BIOLOGICAL ASPECT OF HUMAN DISEASE: STUDY OF GLIOBLASTOMA BY USING COMPARATIVE GENOMIC HYBRIDIZATION (CGH) METHOD

    Glioblastoma is a WHO grade IV tumor with high mortality rate. In order to identify the underlying biological causation of this disease, a comparative genomic hybridization dataset generated from 170 patients' tumor samples was analyzed. Of many available segmentation algorithms, I focused mainly …

    maryland Repository record for USING STATISTICAL METHOD TO REVEAL BIOLOGICAL ASPECT OF HUMAN DISEASE: STUDY OF GLIOBLASTOMA BY USING COMPARATIVE GENOMIC HYBRIDIZATION (CGH) METHOD (opens in a new tab)

  14. The influence of host-derived osteopontin on glioma

    Glioblastoma multiforme (WHO Grade IV) is the most common malignant neoplasm of the brain. Hallmarks of WHO grade IV designated tumors are a rapid pre- and postoperative disease evolution and a fatal outcome. Those features are also reflected in the low overall survival rate of GBM patients of …

    fu-berlin Repository record for The influence of host-derived osteopontin on glioma (opens in a new tab)

  15. Predicting Meningioma Recurrence Using Spectrochemical Analysis of Tissues and Subsequent Predictive Computational Algorithms

    … nervous system (CNS) and are classified as WHO grades (1,2 ,&3) depending on histological sub-type, tumour growth rate and the likelihood of recurrence. The majority of meningioma are benign, yet, around 10% will recur following resection. Variation in follow-up of patients comes with …

    cent-lancashire Repository record for Predicting Meningioma Recurrence Using Spectrochemical Analysis of Tissues and Subsequent Predictive Computational Algorithms (opens in a new tab) Download PDF for Predicting Meningioma Recurrence Using Spectrochemical Analysis of Tissues and Subsequent Predictive Computational Algorithms (opens in a new tab)

  16. Tissue Mechanics Govern Tumor Quiescence and Chemosensitivity in Medulloblastoma

    … prevalent malignant brain tumor in children (WHO grade 4) that encompasses a heterogeneous group of cerebellar or brainstem embryonal tumors. Current standard-of-care is met with therapy resistance and associated with severe neurocognitive, neuroendocrine, and psychosocial side effects. …

    toronto-retro Repository record for Tissue Mechanics Govern Tumor Quiescence and Chemosensitivity in Medulloblastoma (opens in a new tab)

  17. The role of meningioma epigenetics in routine clinical practice

    … μέχρι και σήμερα το σύστημα ταξινόμησης κατά WHO. Στην ανανεωμένη έκδοση κατά WHO ενσωματώνονται μοριακοί βιοδείκτες. Το προφίλ μεθυλίωσης των μηνιγγιωμάτων παρότι φάνηκε να είναι ένας αξιόπιστος προγνωστικός παράγοντας της υποτροπής και της πορείας των μηνιγγιωμάτων, δεν έχει ακόμη …

    athens Repository record for The role of meningioma epigenetics in routine clinical practice (opens in a new tab)

  18. Biomarkers and predictors in glioblastoma recurrence

    … diagnosed with glioblastoma (IDH-wildtype, grade 4) survive more than two years despite intense treatment. A crucial aspect of their rapid progression may lie in the tumors' ability to quickly form recurrences that become increasingly more aggressive and resistant to therapy. New ways to …

    wurz-thes Repository record for Biomarkers and predictors in glioblastoma recurrence (opens in a new tab)

Page 1 of 3